Literature DB >> 10435769

Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice.

A Honig1, B M Arts, R W Ponds, W J Riedel.   

Abstract

Qualitative analysis of the literature on cognitive side-effects of lithium in patients with a bipolar disorder identified four of 17 studies that fulfilled criteria of adequate methodological quality. Analysis of these four studies showed that lithium had a negative effect on memory and speed of information processing, often without subjective complaints or awareness of mental slowness. The consequences of these findings for daily practice are discussed, in particular with respect to driving performance. When neurocognitive complaints or deficits are present, lithium plasma level, thyroid functions and degree of mood disturbance should be assessed. In cases where all these parameters are within normal limits and neurocognitive complaints still persist, dose reduction of lithium, thyroid hormone addition, prescription of a slow release preparation or replacement of lithium by another moodstabiliser should be considered. Guidelines are suggested with respect to further neuropsychological screening.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435769

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  23 in total

1.  Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort.

Authors:  Mahyar Etminan; Brenda Hemmelgarn; J A C Delaney; Samy Suissa
Journal:  BMJ       Date:  2004-01-19

2.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

3.  Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success.

Authors:  Hans F Fuchs; Vanessa Laughter; Cristina R Harnsberger; Ryan C Broderick; Martin Berducci; Christopher DuCoin; Joshua Langert; Bryan J Sandler; Garth R Jacobsen; William Perry; Santiago Horgan
Journal:  Surg Endosc       Date:  2015-04-07       Impact factor: 4.584

Review 4.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 5.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 6.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

Review 7.  The effects of lithium on cognition: an updated review.

Authors:  Arlin K Pachet; Amy M Wisniewski
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

8.  Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chris C Streeter; Yosef A Berlow; Hua Tian; Megan Wardrop; Chelsea T Finn; David Harper; Perry F Renshaw; Constance M Moore
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

Review 9.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 10.  Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.